Jointly provided by Purdue University College of Pharmacy and the Academy for Continued Healthcare Learning (ACHL)
Pharmacist’s Guide to Clinical Decision Making in Anticoagulant Therapy for Stroke Prevention in Atrial Fibrillation
| Overview / Abstract: |
Atrial fibrillation (AF) is the most common type of arrhythmia affecting an estimated 2.66 million people in the United States in 2010 and that number is expected to increase to as many as 12 million people by 2050. This condition is associated with substantially increased risk for ischemic stroke as well as morbidity and mortality; moreover, treatment of AF represents a significant healthcare burden with an estimated cost of $6.65 billion per year, including the costs of hospitalization, in- and outpatient physician care, and medications. |
|
Expiration |
Sep 19, 2015 |
|
Discipline(s) |
Pharmacy CPE |
|
Format |
Webinar / Webcast / Video |
|
Credits / Hours |
1.0 |
|
Accreditation |
Purdue University College of Pharmacy is accredited by the ACCME as a provider of continuing pharmacy education |
|
Is This Activity Certified for "Live" Credit? |
YES |
|
Presenters / Authors / Faculty |
Edith Nutescu, PharmD, MS, FCCP |
|
Activity Specialities / Related Topics |
Anticoagulation / Thrombosis, Pharmacology, Preventive Care |
|
Sponsors / Supporters / Grant Providers |
Funds for this webcast have been provided by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Daiichi Sankyo, Inc. |
|
Keywords / Search Terms |
ACHL Cardiology, Cardiovascular, Interventional Cardiologist, Pharmacist, Pharmacy, Stroke, Atrial Fibrillation, Anticoagulant, Anticoagulation Free CE CME Live CE CME |
|